| Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection DHT Mya, ST Han, YC Linn, WYK Hwang, YT Goh, DCL Tan Annals of oncology 23 (2), 421-426, 2012 | 50 | 2012 |
| Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy M Lechner, VH Schartinger, CD Steele, WL Nei, ML Ooft, LM Schreiber, ... Nature Communications 12 (1), 117, 2021 | 46 | 2021 |
| Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis S Han, Q Zhuang, J Chiang, SH Tan, GWY Chua, C Xie, MLK Chua, ... BMJ open 12 (2), e044661, 2022 | 42 | 2022 |
| Epstein–Barr virus epithelial cancers—A comprehensive understanding to drive novel therapies S Han, JK Tay, CJL Loh, AJM Chu, JPS Yeong, CM Lim, HC Toh Frontiers in Immunology 12, 734293, 2021 | 35 | 2021 |
| A perspective on cell therapy and cancer vaccine in biliary tract cancers (BTCs) S Han, SY Lee, WW Wang, YB Tan, RHZ Sim, R Cheong, C Tan, ... Cancers 12 (11), 3404, 2020 | 20 | 2020 |
| Monocytic myeloid-derived suppressor cells underpin resistance to adoptive T cell therapy in nasopharyngeal carcinoma R Hopkins, W Xiang, D Marlier, VB Au, Q Ching, LX Wu, R Guan, B Lee, ... Molecular Therapy 29 (2), 734-743, 2021 | 15 | 2021 |
| Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer Centre J Chiang, VS Yang, S Han, Q Zhuang, G Ooi, IH Sin, GWY Chua, SY Tan, ... Journal of Cancer Policy 25, 100241, 2020 | 14 | 2020 |
| Tailoring precision immunotherapy: coming to a clinic soon? S Han, WH Shuen, WW Wang, E Nazim, HC Toh ESMO open 5, e000631, 2020 | 11 | 2020 |
| The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers S Han, AY Chok, DYY Peh, JZM Ho, EKW Tan, SL Koo, IBH Tan, JCA Ong Frontiers in Genetics 13, 933475, 2022 | 4 | 2022 |
| Pathogenesis and therapeutic implications of EBV-associated epithelial cancers YH Low, CJL Loh, DYY Peh, AJM Chu, S Han, HC Toh Frontiers in Oncology 13, 2023 | 2 | 2023 |
| Defining precision cellular immunotherapy—seeking biomarkers to predict and optimize outcomes of T cell therapies in cancer HCT Shuting Han, Who-Whong Wang, Esdy Rozali Precision Cancer Medicine 2, 2019 | 2 | 2019 |
| Oncology workload in a tertiary hospital during the COVID-19 pandemic J Chiang, V Yang, S Han, Q Zhuang, S Zhou, S Mathur, ML Kang, ... Proceedings of Singapore Healthcare 31, 20101058211051118, 2022 | 1 | 2022 |
| A case of metastatic lymphoepithelial carcinoma of parotid gland identified on 68gallium DOTA-[Tyr3] octreotate PET CT HC Low, KSH Loke, FQ Wang, S Han, A Jain, J Yeong, WL Nei BJR| Case Reports 10 (1), uaad011, 2024 | | 2024 |
| 68Ga-DOTATATE PET/CT of Metastatic Lymphoepithelial Carcinoma of Parotid Gland HC Low, KSH Loke, FQ Wang, S Han, WL Nei Clinical Nuclear Medicine 48 (12), 1056-1058, 2023 | | 2023 |
| Oncology patients with pulmonary infiltrates in the COVID-19 era: a case series ECY Sng, S Han, VS Yang, BH Tan Singapore Medical Journal 64 (10), 616-619, 2023 | | 2023 |
| P09. 06 Investigating various patient parameters as prognostic markers for patients with advance stage nasopharyngeal carcinoma undergoing induction chemotherapy followed by … A Chu, S Han, H Toh Journal for ImmunoTherapy of Cancer 9 (Suppl 1), 2021 | | 2021 |
| The empowerment of all modalities against cancer S Han, HC Toh Singapore medical journal 59 (11), 560, 2018 | | 2018 |
| Somatostatin receptor imaging in nasopharyngeal cancer WL Nei, A Jain, FQ Wang, LK Khor, JPS Yeong, ST Han, K Sommat, ... Annals of Nasopharynx Cancer 2 (2), 2018 | | 2018 |
| Risk of Hepatitis B Virus (HBV) Reactivation and the Role of Anti-Viral Prophylaxis in Multiple Myeloma Patients with HBV Infection in the Era of Novel Therapies. D Mya, S Han, YT Goh, D Tan Blood 114 (22), 3882, 2009 | | 2009 |
| 00516 Somatostatin Receptor 2 Expression and Clinical Significance in Pulmonary Lymphoepithelioma-like Carcinoma H Shuting, N Wenlong, J Yeong, C Lim, LJ Hua, A Mei-Kim, D Lim, ... | | |
